Invesaro

Stocks SPXC Financial statements

Financial statements

SPX Technologies, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SPX Technologies, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,4721,4261,5131,1241,1281,2201,4611,7411,9842,265
Cost of revenue1,0971,0961,1037227337889371,0711,1851,347
Gross profit376330410402396432524670799918
Research and development29.123.322.924.328.130.739.143.245.954
Selling, general and administrative286277289276273310356394415478
Operating income7059.911311496.973.751222308350
Interest expense14.817.121.52118.413.19.327.245.748.1
Interest income0.81.31.51.60.20.51.71.72.14.8
Other non-operating income-15.3-7.1-7.6-5.2-0.19-15.2-10.1-9.38.5
Pre-tax income39.436.184.588.878.669.927.1186255314
Income tax9.1-47.92.612.54.810.97.341.653.668.6
Income from continuing operations12.68481.976.373.85919.8145202246
Net income to minority interests-0.400000
Net income-67.289.381.265.3994250.289.9201244
EBITDA96.585.114013812911697.4285400473
EPS, basic-2.052.111.891.612.229.390.001.974.345.10
EPS, diluted-2.022.031.821.582.169.150.001.934.265.03
Shares, basic (weighted)41.642.443.143.944.645.345.345.546.247.8
Shares, diluted (weighted)42.243.944.74545.846.546.246.647.148.5

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents99.612468.550.76438814899.4157364
Receivables252268269265211223264280314357
Inventory146143129155155190244277271302
Other current assets30.697.740.59388.473.141.937.131.555.3
Total current assets5286335986326759037217107841,144
Property, plant and equipment196187184179107113110141218291
Lease right-of-use assets30.640.541.746.342.457.976.8
Goodwill3403463943183694574557058351,043
Intangible assets118118198252305416402681703868
Other non-current assets681707658606592676197189164250
Total assets1,9132,0402,0582,1682,3342,6291,9312,4402,7153,605
Accounts payable138160154141102120125119128145
Accrued liabilities304293184220207218148169171185
Deferred revenue079.510138.844.752.873.562.3116
Short-term debt17.90.51817.213217.327.63.5
Total current liabilities476461470609572440334401418461
Long-term debt324349332250304231243523577497
Lease liabilities17.630.931.533.828.544.561.4
Other non-current liabilities879886817747741789208204224246
Total liabilities1,7211,7261,6341,6231,6941,5268521,2451,3301,367
Total debt17.90.51817.213217.327.63.5
Paid-in capital1,3081,3101,2951,3021,3201,3341,3381,3541,3741,938
Retained earnings-832-742-650-585-477-51.8-51.638.3239483
Treasury stock-520-503-476-460-452-444-466-459-452-445
Other comprehensive income235250245244249264258261224261
Shareholders' equity1923154155126401,1031,0791,1951,3842,238
Minority interests0
Total equity1923154245126401,1031,0791,1951,3842,238
Total liabilities and equity1,9132,0402,0582,1352,3342,6291,9312,4402,7153,605
Shares outstanding41.942.743.544.24545.545.345.746.449.9

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-67.689.381.265.3994250.289.9201244
Depreciation and amortization26.525.227.924.431.942.346.463.291.6123
Stock-based compensation13.715.815.512.613.112.810.913.41516.7
Deferred income tax0-210.913.80.3-1.4-21.4-25.2-15.126.1
Change in inventory8.54.52.9-8.80-21-53.4-3.19.12.8
Change in payables-40.228.3-77.1-56.1-56.145.8-73.77-4.324.7
Cash from operations-1.246.9111149126175-137209286333
Capital expenditures-11.7-11-12.4-13.5-15.3-9.6-15.9-23.9-38-92.1
Acquisitions00-181-147-104-265-40-547-292-445
Cash from investing13.2-10.6-181-154-126314-66.1-570-285-561
Debt issued1625173376913323902451,0476571,259
Debt repaid-181-519-312-681-316-554-245-735-602-1,372
Stock issued00551
Share buybacks000-33.700
Dividends paid00
Cash from financing-20.5-6.216.8-11.115.9-168-38.931053.1426
Exchange rate effect6.7-5.4-2.32.1-2.56.62.9-0.126.8
Net change in cash-1.824.7-55.5-14.113.6328-239-52.256.5205
Free cash flow-12.935.998.2135111165-153185248241
Interest paid12.515.119.716.117.511.46.525.643.441.7
Income taxes paid-4.8-22.9-44.377.6-5.5-59.658.443.557.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $172.79 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin40.2%Gross profit / revenue.
Operating margin16.2%Operating income / revenue.
EBITDA margin21.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin14.8%Pre-tax income / revenue.
Net margin11.3%Net income / revenue.
FCF margin12.3%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin17.0%Cash from operations / revenue.
Effective tax rate22.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)11.9%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)7.1%Net income / average total assets.
Return on invested capital (ROIC)14.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue20.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.7%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.8%Capital expenditures / revenue.
D&A / revenue5.3%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y14.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y15.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y15.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y14.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y20.5%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y18.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y13.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y90.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y29.3%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y18.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y69.3%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y29.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y21.7%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y968.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y19.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y18.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y18.4%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y16.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y21.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-2.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y16.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y61.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y27.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y28.4%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y32.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y23.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.1%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y1.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.82xCurrent assets / current liabilities.
Quick ratio1.01x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.28x(Cash + short-term investments) / current liabilities.
Debt / equity0.00xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets0.3%Total debt / total assets.
Liabilities / assets40.4%Total liabilities / total assets.
Net debt-$156.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.29xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage10.7xOperating income / interest expense.
Working capital$498.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets57.1%(Goodwill + intangible assets) / total assets.
Tangible book value$98.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.63xRevenue / average total assets.
Fixed asset turnover7.62xRevenue / average property, plant and equipment.
Inventory turnover3.96xCost of revenue / average inventory.
Days inventory92 days365 x average inventory / cost of revenue.
Receivables turnover5.60xRevenue / average receivables.
Days sales outstanding65 days365 x average receivables / revenue.
Days payables48 days365 x average accounts payable / cost of revenue.
Cash conversion cycle109 daysDays inventory + days sales outstanding - days payables.
FCF conversion108.8%Free cash flow / net income, when net income is positive.
Capex / operating cash flow28.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$48.86Revenue / diluted weighted shares.
FCF per share$5.99Free cash flow / diluted weighted shares.
Operating cash flow per share$8.33Cash from operations / diluted weighted shares.
Book value per share$46.89Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.97Tangible book value / shares outstanding.
Cash per share$3.32(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$8.65BShare price x shares outstanding.
Enterprise value$8.50BMarket cap + total debt - cash - short-term investments.
P/E31.0xMarket cap / net income. Only when net income is positive.
P/S3.50xMarket cap / revenue.
P/B3.69xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book87.6xMarket cap / tangible book value, when positive.
P/FCF28.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF20.5xMarket cap / cash from operations, when positive.
EV/Sales3.43xEnterprise value / revenue.
EV/EBIT21.2xEnterprise value / operating income, when both are positive.
EV/EBITDA16.0xEnterprise value / EBITDA, when both are positive.
EV/FCF28.0xEnterprise value / free cash flow, when both are positive.
FCF yield3.5%Free cash flow / market cap.
Earnings yield3.2%Net income / market cap (the inverse of P/E).
What was SPX Technologies, Inc.'s revenue in fiscal 2025?

SPX Technologies, Inc. reported revenue of $2.27B for fiscal 2025, 14.2% higher than the year before.

Was SPX Technologies, Inc. profitable in fiscal 2025?

Yes. Net income was $244.0M, a net margin of 10.8%.

How much free cash flow did SPX Technologies, Inc. generate in fiscal 2025?

Cash from operations of $333.3M minus capital expenditures of $92.1M left free cash flow of $241.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SPX Technologies, Inc.